
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
Marpai Inc (MRAI)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: MRAI (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $6
1 Year Target Price $6
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -59.68% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 21.24M USD | Price to earnings Ratio - | 1Y Target Price 6 |
Price to earnings Ratio - | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta 4.64 | 52 Weeks Range 0.43 - 1.68 | Updated Date 09/14/2025 |
52 Weeks Range 0.43 - 1.68 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.92 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -51.35% | Operating Margin (TTM) -77.47% |
Management Effectiveness
Return on Assets (TTM) -40.88% | Return on Equity (TTM) -1359.59% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 24461141 | Price to Sales(TTM) 0.9 |
Enterprise Value 24461141 | Price to Sales(TTM) 0.9 | ||
Enterprise Value to Revenue 0.7 | Enterprise Value to EBITDA -0.89 | Shares Outstanding 17270000 | Shares Floating 9053125 |
Shares Outstanding 17270000 | Shares Floating 9053125 | ||
Percent Insiders 49.81 | Percent Institutions 10.8 |
Upturn AI SWOT
Marpai Inc
Company Overview
History and Background
Marpai, Inc. (MRAI) is a technology company focused on developing artificial intelligence (AI) solutions for third-party administrators in the healthcare industry. While a relatively newer company, its formation and initial success is based on integrating technology within healthcare benefits.
Core Business Areas
- Third-Party Administration (TPA) Services: Marpai provides TPA services using AI to manage healthcare claims, process payments, and provide data analytics.
- AI-Powered Platform: Their core offering is an AI platform to optimize healthcare spending and improve health outcomes. This includes claim processing, care navigation, and cost containment.
Leadership and Structure
The leadership team consists of experienced executives in technology and healthcare. Details on specific individuals and the precise organizational structure can be found on Marpai's investor relations website or public filings.
Top Products and Market Share
Key Offerings
- Marpai Rx Navigator: AI-powered pharmacy benefits solution helping optimize drug costs. Market share data for this specific product is not readily available. Competitors: CVS Caremark, Express Scripts, OptumRx.
- Smart Claim Negotiation: AI that negotiates claims to reduce costs. Precise market share unavailable. Competitors: Accolade, Quantum Health.
Market Dynamics
Industry Overview
The healthcare benefits administration industry is large and growing, driven by rising healthcare costs and increasing demand for technology-driven solutions. AI adoption is still in early stages but accelerating.
Positioning
Marpai positions itself as a technology disruptor in the TPA space, offering AI-driven solutions to improve efficiency and reduce costs. Their competitive advantage lies in its AI platform.
Total Addressable Market (TAM)
The TAM for AI in healthcare benefits administration is estimated to be in the tens of billions of dollars. Marpai is positioned to capture a share of this market through its innovative AI platform.
Upturn SWOT Analysis
Strengths
- Proprietary AI technology
- Focus on cost containment
- Scalable platform
- Experienced leadership team
Weaknesses
- Limited operating history
- Small market share compared to large competitors
- Dependence on key personnel
- High operating costs
Opportunities
- Growing demand for AI in healthcare
- Expansion into new markets
- Strategic partnerships
- Acquisition opportunities
Threats
- Competition from established players
- Rapid technological changes
- Regulatory changes
- Economic downturn
Competitors and Market Share
Key Competitors
- UNH
- CI
- HUM
- THC
Competitive Landscape
Marpai faces intense competition from large, established players. Its AI technology and focus on cost containment provide a competitive edge, but significant challenges remain in gaining market share.
Growth Trajectory and Initiatives
Historical Growth: Marpai is experiencing growth, but it has had fluctuating revenue results.
Future Projections: Analyst projections for Marpai's future growth are not readily available and may vary depending on the source. Check analyst estimates.
Recent Initiatives: Focus on platform improvement, strategic partnerships, and sales and marketing initiatives.
Summary
Marpai is a technology company attempting to disrupt the healthcare benefits administration industry with its AI-driven solutions. While it boasts a unique AI platform and focuses on cost containment, it is constrained by its limited history and relatively small market share. The company must effectively compete with larger, more established players and continue to innovate to solidify its position in the market, however its limited capital makes this exceedingly difficult. Market perception is also an issue with the stock regularly targeted by short sellers.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings (10-K, 10-Q)
- Company website
- Industry reports
- Analyst reports (if available)
Disclaimers:
This analysis is based on available information and is not financial advice. Market conditions and company performance are subject to change. Conduct thorough research before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Marpai Inc
Exchange NASDAQ | Headquaters Tampa, FL, United States | ||
IPO Launch date 2021-10-27 | CEO & Director Mr. Damien Francis Lamendola | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 117 | Website https://www.marpaihealth.com |
Full time employees 117 | Website https://www.marpaihealth.com |
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.